Drugs Made In America Acquisition DMAA

EPS, diluted: Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Companies in Financial Services nearest Drugs Made In America Acquisition's size, closest first.

Company	Market cap	PE	Its 10y median PE	Fwd PE	P/S	Revenue growth	Net margin
DMAADrugs Made In America Acquisition	$264M	n/m	49.4×		n/m	n/m	n/m
RMBIRichmond Mutual Bancorporation	$266.5M	13.1×	13.1×		n/m	+15%	23.1%
VABKVirginia National Bankshares	$269.6M	10.9×	12.1×		n/m	+13%	39.0%
NKSHNational Bankshares	$257.9M	12.7×	16.5×		n/m	+21%	33.6%
FXNCFirst National	$271.1M	12.5×	10.8×		n/m	+12%	23.3%
HWBKHawthorn Bancshares	$271.1M	10.7×	10.2×		n/m	+12%	30.0%
EFSIEagle Financial Services	$254M	13.6×	11.2×		n/m	+37%	20.6%
FNRNFirst Northern Community Bancorp	$275.6M	12.5×	7.9×		n/m	+5%	30.0%
GBFHGBank Financial	$252.2M	13.6×	19.8×		n/m	+20%	22.4%
WNEBWestern New England Bancorp	$278.2M	16.5×	16.4×		n/m	+17%	19.0%
SNFCASecurity National Financial	$250.5M	6.4×	5.8×		0.7×	−1%	11.1%
Peer median	$268M	12.6×	11.6×		0.7×	+14%	23.2%

Each number over time

• Market cap
• EPS
• Shares outstanding

Its groups

• Shell Companies
• Financial Services

Industry

Shell Companies

Sector

Financial Services